Antihypertensive Efficacy of Irbesartan/HCTZ in Men and Women With the Metabolic Syndrome and Type 2 Diabetes

This subgroup analysis of the Irbesartan/Hydrochlorothiazide (HCTZ) Blood Pressure Reductions in Diverse Patient Populations (INCLUSIVE) trial evaluated the efficacy and safety of irbesartan/HCTZ fixed combinations in adults with uncontrolled systolic blood pressure (SBP) (140–159 mm Hg; 130–159 mm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Hypertens (Greenwich)
Autores principales: Sowers, James R., Neutel, Joel M., Saunders, Elijah, Bakris, George L., Cushman, William C., Ferdinand, Keith C., Ofili, Elizabeth O., Weber, Michael A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Le Jacq Ltd. 2007
Materias:
Original Papers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109400/
https://ncbi.nlm.nih.gov/pubmed/16849900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2006.05486.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares